Abstract
Background
Recurrent laryngeal nerve (RLN) palsy and hypoparathyroidism are serious complications in thyroid and parathyroid surgery. The extent to which incidentally detected thyroid nodules should be treated concomitantly is a matter of debate.
Methods
This analysis was based on 1,065 patients who underwent consecutive surgery for primary hyperparathyroidism at a single institution. Together with the surgical strategy, histologic and follow-up examinations were documented prospectively and analyzed retrospectively regarding the occurrence and course of RLN palsy, hypoparathyroidism, and thyroid carcinoma.
Results
Altogether, RLN palsy occurred for 38 patients (3.6 %) and proved to be permanent for 1 patient (0.1 %). Postoperative calcium substitution was necessary for 191 patients (17.9 %), with 3 patients showing permanent hypoparathyroidism (0.3 %). Procedures other than open minimally invasive exploration were accompanied by a significantly increased risk for temporary RLN paresis (odds ratio [OR], 6.136) and temporary hypoparathyroidism (OR 3.306). Concomitant thyroid surgery was performed for 502 patients (47.1 %). Compared with open minimally invasive parathyroid exploration, patients undergoing unilateral exploration and hemithyroidectomy (OR 5.827) or bilateral neck exploration (BNE) and thyroidectomy (OR 8.047) had a significantly increased risk for RLN paresis. Patients administered BNE with hemithyroidectomy (OR 2.380) or thyroidectomy (OR 7.233) had a significantly increased risk for hypoparathyroidism. Thyroid malignancy was incidentally detected in 86 patients (8.1 %).
Conclusion
Patients undergoing concomitant thyroid procedures have a significantly higher risk for temporary RLN palsy and hypoparathyroidism. However, the high rate of incidentally detected thyroid carcinoma in an iodine-replete endemic goiter area indicates hemithyroidectomy in the presence of thyroid nodules incidentally identified in preoperative ultrasounds.
Similar content being viewed by others
References
van Heerden JA, Grant CS. Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg. 1991;15:688–692.
Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235:665–670; discussion 670–662.
Prager G, Passler C, Scheuba C, Udelsman R, Gasparri G, Niederle B. Minimally invasive open parathyroidectomy: a review. Acta Chir Austriaca. 1991;31:221–226.
Monroe DP, Edeiken-Monroe BS, Lee JE, Evans DB, Perrier ND. Impact of preoperative thyroid ultrasonography on the surgical management of primary hyperparathyroidism. Br J Surg. 2008;95:957–960.
Gates JD, Benavides LC, Shriver CD, Peoples GE, Stojadinovic A. Preoperative thyroid ultrasound in all patients undergoing parathyroidectomy? J Surg Res. 2009;155:254–260.
Morita SY, Somervell H, Umbricht CB, Dackiw AP, Zeiger MA. Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. Surgery. 2008;144:862–866; discussion 866–8.
Wang TS, Roman SA, Cox H, Air M, Sosa JA. The management of thyroid nodules in patients with primary hyperparathyroidism. J Surg Res. 2009;154:317–323.
Bergenfelz A, Jansson S, Kristoffersson A, et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbecks Arch Surg. 2008;393:667–673.
Serpell JW, Phan D. Safety of total thyroidectomy. ANZ J Surg. 2007;77:15–19.
Enomoto K, Uchino S, Watanabe S, Enomoto Y, Noguchi S. Recurrent laryngeal nerve palsy during surgery for benign thyroid diseases: risk factors and outcome analysis. Surgery. 2014;155:522–528.
Higgins TS, Gupta R, Ketcham AS, Sataloff RT, Wadsworth JT, Sinacori JT. Recurrent laryngeal nerve monitoring versus identification alone on post-thyroidectomy true vocal fold palsy: a meta-analysis. Laryngoscope. 2011;121:1009–1017.
Gupta PK, Smith RB, Gupta H, Forse RA, Fang X, Lydiatt WM. Outcomes after thyroidectomy and parathyroidectomy. Head Neck. 2012;34:477–484.
Witteveen JE, van Thiel S, Romijn JA, Hamdy NA. Hungry bone syndrome: still a challenge in the postoperative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol. 2013;168:R45–R53.
Prager G, Czerny C, Kurtaran A, et al. Minimally invasive open parathyroidectomy in an endemic goiter area: a prospective study. Arch Surg. 2001;136:810–816.
Riss P, Kaczirek K, Heinz G, Bieglmayer C, Niederle B. A “defined baseline” in PTH monitoring increases surgical success in patients with multiple gland disease. Surgery. 2007;142:398–404.
Kosmidis I, Firth D. Bias reduction in exponential family nonlinear models. Biometrika. 2009;96:793–804.
Asari R, Passler C, Kaczirek K, Scheuba C, Niederle B. Hypoparathyroidism after total thyroidectomy: a prospective study. Arch Surg. 2008;143:132–137; discussion 138.
Bergenfelz A, Kanngiesser V, Zielke A, Nies C, Rothmund M. Conventional bilateral cervical exploration versus open minimally invasive parathyroidectomy under local anaesthesia for primary hyperparathyroidism. Br J Surg. 2005;92:190–197.
Strichartz SD, Giuliano AE. The operative management of coexisting thyroid and parathyroid disease. Arch Surg. 1990;125:1327–1331.
Riss P, Scheuba C, Asari R, Bieglmayer C, Niederle B. Is minimally invasive parathyroidectomy without QPTH monitoring justified? Langenbeck’s Arch Surg. 2009;394:875–880.
Prager G, Czerny C, Ofluoglu S, et al. Impact of localization studies on feasibility of minimally invasive parathyroidectomy in an endemic goiter region. J Am Coll Surg. 2003;196:541–548.
Eid I, Miller FR, Rowan S, Otto RA. The role of nerve monitoring to predict postoperative recurrent laryngeal nerve function in thyroid and parathyroid surgery. Laryngoscope. 2013;123:2583–2586.
Snyder SK, Sigmond BR, Lairmore TC, Govednik-Horny CM, Janicek AK, Jupiter DC. The long-term impact of routine intraoperative nerve monitoring during thyroid and parathyroid surgery. Surgery. 2013;154:704–711; discussion 711–703.
Asari R, Niederle BE, Scheuba C, et al. Indeterminate thyroid nodules: a challenge for the surgical strategy. Surgery. 2010;148:516–525.
Thomusch O, Machens A, Sekulla C, Ukkat J, Brauckhoff M, Dralle H. The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients. Surgery. 2003;133:180–185.
Grover G, Sadler GP, Mihai R. Morbidity after thyroid surgery: patient perspective. Laryngoscope. 2013;123:2319–2323.
Lombardi CP, Raffaelli M, Traini E, De Crea C, Corsello SM, Bellantone R. Video-assisted minimally invasive parathyroidectomy: benefits and long-term results. World J Surg. 2009;33:2266–2281.
Schlosser K, Zeuner M, Wagner M, et al. Laryngoscopy in thyroid surgery: essential standard or unnecessary routine? Surgery. 2007;142:858–864; discussion 864 e851–2.
Dralle H, Lorenz K, Machens A. State of the art: surgery for endemic goiter: a plea for individualizing the extent of resection instead of heading for routine total thyroidectomy. Langenbecks Arch Surg. 2011;396:1137–1143.
Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study. Eur J Endocrinol. 2006;155:237–244.
Press D, Politz D, Lopez J, Norman J. The effect of vitamin D levels on postoperative calcium requirements, symptomatic hypocalcemia, and parathormone levels following parathyroidectomy for primary hyperparathyroidism. Surgery. 2011;150:1061–1068.
Rolighed L, Rejnmark L, Sikjaer T, et al. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J Clin Endocrinol Metab. 2014;99:1072–1080.
Westerdahl J, Bergenfelz A. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg. 2007;246:976–980; discussion 980–971.
Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg. 2002;236:543–551.
Ito Y, Tomoda C, Uruno T, et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg. 2006;30:91–99.
Ito Y, Higashiyama T, Takamura Y, et al. Prognosis of patients with benign thyroid diseases accompanied by incidental papillary carcinoma undetectable on preoperative imaging tests. World J Surg. 2007;31:1672–1676.
Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, Fujimoto Y. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg. 2010;34:1222–1231.
Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24:27–34.
Goretzki PE, Lyons J, Stacy-Phipps S, et al. Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications. World J Surg. 1992;16:576–581; discussion 581–572.
Conflict of interest
There are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Riss, P., Kammer, M., Selberherr, A. et al. Morbidity Associated with Concomitant Thyroid Surgery in Patients with Primary Hyperparathyroidism. Ann Surg Oncol 22, 2707–2713 (2015). https://doi.org/10.1245/s10434-014-4283-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-014-4283-4